What is longevity medicine and why is it going mainstream?

Longevity medicine is a branch of preventive healthcare focused on extending healthspan, the number of years you live in good physical and cognitive health, rather than simply treating disease after it appears. It combines targeted supplementation, biomarker monitoring, peptide therapies, metabolic optimisation, and lifestyle interventions to slow biological aging and reduce the risk of age-related decline. The global longevity and anti-aging market was valued at approximately USD 63 billion in 2024 and is projected to exceed USD 93 billion by 2030, according to Grand View Research.

What makes longevity medicine different from general wellness is its emphasis on measurement. Practitioners track specific biomarkers (like ApoB, HbA1c, IGF-1, and inflammatory markers) over time and adjust interventions based on data, not symptoms. Think of it less as "anti-aging" and more as ongoing health maintenance informed by your own biology.

Why is longevity medicine going mainstream now?

Three forces are converging. First, the science is catching up to the hype. Clinical trials on compounds like NMN, rapamycin, metformin, and GLP-1 receptor agonists are producing measurable results in humans, not just mice. A 2024 study from the University of Washington showed that NMN supplementation improved NAD+ levels and muscle insulin sensitivity in prediabetic women. Separately, the TAME (Targeting Aging with Metformin) trial, one of the first large-scale aging intervention studies, has accelerated interest in treating aging as a modifiable condition rather than an inevitability.

Second, the tools are becoming accessible. Wearable devices like Oura Ring, Whoop, and Apple Watch now track sleep architecture, HRV, and recovery with clinical-grade accuracy. Direct-to-consumer blood testing from services like SiPhox Health and Function Health make comprehensive biomarker panels available without a doctor's referral. The data that used to require a $10,000 executive health screening is now available for a fraction of that cost.

Third, high-profile advocates have normalised the conversation. Bryan Johnson's Blueprint protocol, Peter Attia's book Outlive, and Andrew Huberman's podcast have brought longevity science to millions of people who would never have read a PubMed abstract. This is creating consumer demand that the healthcare industry is now scrambling to serve.

What does a longevity protocol actually include?

A typical longevity-focused health plan covers several layers, starting with the simplest interventions and escalating based on goals, data, and medical guidance:

• Foundational supplements: Vitamin D3+K2, omega-3 fatty acids, magnesium, and creatine. These address common deficiencies and support cellular function. Most longevity physicians consider these baseline recommendations for nearly everyone.
• Targeted compounds: NMN or NR (NAD+ precursors), CoQ10, and specific antioxidants selected based on biomarker data and health goals.
• Peptide therapies: Compounds like BPC-157 (for gut and tissue repair), GHK-Cu (for skin and wound healing), and sermorelin (for growth hormone optimisation). Some are available in oral or topical form, while others require a prescription and clinical supervision.
• Metabolic interventions: GLP-1 receptor agonists (originally developed for diabetes, now used for metabolic health and body composition), metformin (being studied for its potential anti-aging effects), and rapamycin (an immunosuppressant being explored at low doses for longevity).
• Lifestyle protocols: Structured exercise (especially zone 2 cardio and resistance training), sleep optimisation, heat and cold exposure (sauna and cold plunge), and stress management.
• Biomarker tracking: Regular blood panels covering metabolic markers, inflammatory markers, hormones, and organ function. Testing every 3 to 6 months allows protocols to be adjusted based on how your body responds.

What's available in Asia right now?

The longevity medicine landscape in Asia is still early compared to the US, but growing fast. Hong Kong has several clinics offering biomarker testing and IV NAD+ therapy, though few combine this with ongoing digital health management. Singapore has a more established telehealth infrastructure, with platforms like NOVI Health offering metabolic health programmes. However, most options in Asia are either high-end concierge medicine (HKD 50,000+ per year) or basic supplement retail with no personalisation.

The gap is in the middle. There's no platform in Asia that combines AI-driven health assessment, personalised supplement recommendations, peptide guidance, wellness experience coordination, and clinical access in one integrated experience at an accessible price point. That's the space we're building KOS Health to fill.

How do you know if longevity medicine is right for you?

Longevity medicine is most valuable for people who are already healthy and want to stay that way for longer. If you're dealing with acute illness, see a doctor first. But if you're a professional in your late 20s to 40s who exercises, eats reasonably well, and wants to optimise what you're already doing, longevity interventions offer a way to be proactive rather than reactive about your health.

The best starting point is a baseline assessment: understand your current health status, identify any gaps (most urban professionals are deficient in vitamin D and magnesium, for example), and build a personalised plan based on your data and goals rather than generic advice from a wellness blog.

What this means for your plan

Longevity medicine is not about living forever. It's about making better-informed decisions about your health using the tools and research now available. Start with what's simple and well-evidenced (foundational supplements, sleep, exercise), measure your baseline with bloodwork and wearable data, and escalate to more advanced interventions like peptides or metabolic therapies only when the data supports it and with proper clinical guidance.